Matched-pair analysis of dendritic cell versus targeted-therapy in patients with metastatic renal cell carcinoma

Although targeted-therapy (TT) for patients with metastatic renal cell cancer (mRCC) has shown an improved outcome, their prognosis is still very poor. Immunotherapy with dendritic cells (DC) as one promising new treatment tries to fight cancer by boosting the patient's own immune system. The p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Anticancer research 2015-03, Vol.35 (3), p.1575-1582
Hauptverfasser:	Isaak, Alexander, Hauser, Stefan, Rogenhofer, Sebastian, Schmidt-Wolf, Ingo G H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Carcinoma, Renal Cell - mortality Carcinoma, Renal Cell - therapy Dendritic Cells - immunology Female Humans Kidney Neoplasms - mortality Kidney Neoplasms - therapy Male Middle Aged Molecular Targeted Therapy Protein-Tyrosine Kinases - antagonists & inhibitors TOR Serine-Threonine Kinases - antagonists & inhibitors Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!